SDC, Materials and Methods
Measurement of Blood Pressure
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured
semirecumbent with a fully automatic upper-arm digital blood pressure monitor (Spot Vital Signs LXi; Welch Allyn). Six readings over an 8- to 10- minute period were taken, with the first reading ignored, and the mean of the remaining 5 used for subsequent derivation of mean arterial pressure (MAP), calculated using the formula MAP=(2DBP+SBP)/3.
Measurement of Body Weight and Height, and Derivation of Body Mass Index
Body weight (kg) and height (m) were measured in a standardised procedure with participants wearing light clothing without shoes. Body weight was measured using a digital scale to the nearest 0.01kg. Body height was measured using a stadiometer with the participants standing without shoes and feet together, to the nearest 0.01m. Body mass index (kg/m
2) was calculated as weight (kg) divided by height squared (m
2).
Measurement of Waist and Neck Circumferences
Waist and neck circumferences (cm) were measured to the nearest 0.1cm with a nonstretchable
standard tape measure. Waist circumference was taken over the unclothed abdomen at the
midpoint of the lower thoracic cage and the iliac crest in the midaxillary line, as recommended
by the World Health Organisation. Neck circumference was measured below the laryngeal
prominence and perpendicular to the long axis of the neck.
Measurement of Triceps Skinfold Thickness
Triceps skinfold thickness (mm), to the nearest 0.2mm, was measured using a skinfold caliper (Holtain, Crymych, UK), on the posterior surface of the upper arm, at the midpoint between the acromial process of the scapula and the tip of the olecranon process of the elbow.
Body Composition Measurement using Bio-impedance Analysis
Body composition was assessed by a well-validated multifrequency bio-impedance based body composition monitor (BCM, Fresenius Medical Care, Germany). Measurements were carried out in a standard manner while the patient was lying supine in a flat and nonconductive bed.
The inbuilt physiological body composition model measures whole-body bio-impedance spectroscopy at 50 frequencies (5-1000 kHz) via electrodes placed on the wrist (proximal to the transverse) and ankle (arch on the superior side of the foot). Body composition data focused on fat tissue and lean tissue mass were expressed as a percentage of body weight.
3-Day Food Diary
Dietary intakes of fructose, dietary fibre, total fat and saturated fat were estimated by a 3-day
food dairy, a widely accepted dietary assessment tool deemed to be valid, reliable and accurate
in estimating typical and habitual nutrient intake. Participants were given detailed written
instructions on completing an accurate dietary record for a 3-day period, which included 1
weekend day, within 1 week before attending the research visit. These instructions were
accompanied by verbal explanation from the researcher, which included training in portion
size estimation and documentation for both dinning in and eating out. The dietary records were
reviewed by the researcher for accuracy and completeness at the research visit. Data were
entered into Dietplan 6 P3 (Forestfield Software Ltd) nutrition analysis program by the same researcher, avoiding interobserver variation. Total intakes of all nutrients were calculated by this program.
General Practice Physical Activity Questionnaire (GPPAQ)
Physical activity was evaluated using the General Practice Physical Activity Questionnaire
(GPPAQ), where participants were asked to estimate weekly number of hours spent on the
following activities: walking; jogging or running; swimming; cycling; exercise or dance
classes; housework; gardening; and other forms of physical activity. The number of hours
engaged in each form of physical activity was summed to provide the weekly total number of
hours spent on performing physical activity.
Table S1: Univariate Associations of Covariates with Obesity (BMI criteria)
Logistic Regression Coefficient* p value Demographic and Social Parameters
Age (years) 0.0071 0.61
Male Gender 0.6680 0.01
Ethnicity:
Non-Caucasian (South Asian, African-Caribbean, and Others) 0.0542 0.84
Diabetes status:
Diabetic Pretransplant
Posttransplant Diabetes Mellitus
0.2782 0.1861
0.06 0.07
Time Posttransplantation (years) 0.0362 0.18
Immunosuppressive Medications:
Calcineurin Inhibitor
Adjunctive Antiproliferative Agent Prednisolone
0.2791 0.9842 0.4162
0.65 0.14 0.04
Total Calorie Intake (kcal/day) 0.4021 0.08
Saturated Fat intake (g/day) 0.0042 0.21
Total Fructose Intake (g/day) 0.0321 <0.001
Physical Activity Level (hours/week) -0.0741 0.09
Sleep Quality (PSQI score) 0.1021 0.03
Endotoxin Level (EU/mL) 0.5382 0.03
UACR (mg/mmol) 0.0162 0.04
*For continuously-distributed variables, coefficient reported per unit increase in predictor variable; for gender, coefficient shown for male versus female.
Table S2: Univariate Associations of Covariates with Metabolic Syndrome
Logistic Regression Coefficient* p value Demographic and Social Parameters
Age (years) 0.0662 0.004
Male Gender 0.3821 0.21
Ethnicity:
Non-Caucasian (South Asian, African-Caribbean, and Others) 0.2102 0.22
Diabetes status:
Diabetic Pretransplant
Posttransplant Diabetes Mellitus
0.6271 0.7821
0.03 0.04
Time Posttransplantation (years) 0.0132 0.62
Immunosuppressive Medications:
Calcineurin Inhibitor
Adjunctive Antiproliferative Agent Prednisolone
1.2021 0.2312 0.1832
0.08 0.45 0.06
Total Calorie Intake (kcal/day) 0.2312 0.44
Saturated Fat intake (g/day) 0.0162 0.29
Total Fructose Intake (g/day) 0.0271 0.002
Physical Activity Level (hours/week) 0.0351 0.19
Sleep Quality (PSQI score) 0.0661 0.13
Endotoxin Level (EU/mL) 0.7632 0.005
UACR (mg/mmol) 0.002 0.67
*For continuously-distributed variables, coefficient reported per unit increase in predictor variable; for gender, coefficient shown for male versus female.
Table S3: Univariate Associations of Covariates with Central Obesity
Logistic Regression Coefficient* p value Demographic and Social Parameters
Age (years) 0.0471 0.003
Male Gender 0.0992 0.28
Ethnicity:
Non-Caucasian (South Asian, African-Caribbean, and Others) 0.0442 0.38
Diabetes status:
Diabetic Pretransplant
Posttransplant Diabetes Mellitus
0.0321 0.0632
0.18 0.09
Time Posttransplantation (years) 0.0412 0.48
Immunosuppressive Medications:
Calcineurin Inhibitor
Adjunctive Antiproliferative Agent Prednisolone
0.3821 0.9212 0.0821
0.55 0.09 0.07
Total Calorie Intake (kcal/day) 0.3214 0.19
Saturated Fat intake (g/day) 0.0172 0.30
Total Fructose Intake (g/day) 0.0498 0.001
Physical Activity Level (hours/week) 0.0312 0.10
Sleep Quality (PSQI score) 0.1102 0.04
Endotoxin Level (EU/mL) 0.4971 0.09
UACR (mg/mmol) 0.0042 0.55
*For continuously-distributed variables, coefficient reported per unit increase in predictor variable; for gender, coefficient shown for male versus female.
Table S4: Univariate Associations of Covariates with Raised Triglycerides
Logistic Regression Coefficient* p value Demographic and Social Parameters
Age (years) 0.0072 0.60
Male Gender 0.6951 0.008
Ethnicity:
Non-Caucasian (South Asian, African-Caribbean, and Others) 0.0591 0.38 Diabetes status:
Diabetic Pretransplant
Posttransplant Diabetes Mellitus
0.6241 0.3215
0.12 0.10
Time Posttransplantation (years) 0.0132 0.37
Immunosuppressive Medications:
Calcineurin Inhibitor
Adjunctive Antiproliferative Agent Prednisolone
0.1062 0.6852 0.0871
0.57 0.28 0.49
Total Calorie Intake (kcal/day) 0.3212 0.26
Saturated Fat intake (g/day) 0.0162 0.02
Total Fructose Intake (g/day) 0.0141 0.02
Physical Activity Level (hours/week) 0.0214 0.59
Sleep Quality (PSQI score) 0.0564 0.23
Endotoxin Level (EU/mL) 0.8962 0.001
UACR (mg/mmol) 0.0091 0.26
Obesity (BMI≥30 kg/m2) 1.1411 0.02
*For continuously-distributed variables, coefficient reported per unit increase in predictor variable; for gender, coefficient shown for male versus female.
Table S5: Univariate Associations of Covariates with Reduced HDL Cholesterol
Logistic Regression Coefficient* p value Demographic and Social Parameters
Age (years) 0.0032 0.83
Male Gender 0.9364 0.001
Ethnicity:
Non-Caucasian (South Asian, African-Caribbean, and Others) 0.7211 0.18 Diabetes status:
Diabetic Pretransplant
Posttransplant Diabetes Mellitus
0.3922 0.3416
0.51 0.43
Time Posttransplantation (years) 0.0251 0.45
Immunosuppressive Medications:
Calcineurin Inhibitor
Adjunctive Antiproliferative Agent Prednisolone
0.7422 0.0441 0.0813
0.49 0.59 0.78
Total Calorie Intake (kcal/day) 0.0821 0.21
Saturated Fat intake (g/day) 0.0122 0.36
Total Fructose Intake (g/day) 0.0182 0.007
Physical Activity Level (hours/week) 0.0711 0.21
Sleep Quality (PSQI score) 0.0412 0.44
Endotoxin Level (EU/mL) 0.9982 0.001
UACR (mg/mmol) 0.0031 0.67
Obesity (BMI≥30 kg/m2) 0.4412 0.19
*For continuously-distributed variables, coefficient reported per unit increase in predictor variable; for gender, coefficient shown for male versus female.
Table S6: Univariate Associations of Covariates with Raised Fasting Glucose
Logistic Regression Coefficient* p value Demographic and Social Parameters
Age (years) 0.0126 0.35
Male Gender 0.8471 0.01
Ethnicity:
Non-Caucasian (South Asian, African-Caribbean, and Others) 0.1601 0.56
Time Posttransplantation (years) 0.0044 0.87
Immunosuppressive Medications:
Calcineurin Inhibitor
Adjunctive Antiproliferative Agent Prednisolone
0.9275 0.8797 0.1718
0.19 0.16 0.69
Total Calorie Intake (kcal/day) 0.0192 0.58
Saturated Fat intake (g/day) 0.0086 0.60
Total Fructose Intake (g/day) 0.0331 <0.001
Physical Activity Level (hours/week) 0.0085 0.37
Sleep Quality (PSQI score) 0.0227 0.63
Endotoxin Level (EU/mL) 0.3372 0.19
UACR (mg/mmol) 0.0015 0.39
Obesity (BMI≥30 kg/m2) 1.1692 0.003
*For continuously-distributed variables, coefficient reported per unit increase in predictor variable; for gender, coefficient shown for male versus female.
Table S7: Univariate Associations of Covariates with Raised Systolic Blood Pressure
Logistic Regression Coefficient* p value Demographic and Social Parameters
Age (years) 0.0521 0.004
Male Gender 0.1901 0.62
Ethnicity:
Non-Caucasian (South Asian, African-Caribbean, and Others) 0.0121 0.73
Diabetes status:
Diabetic Pretransplant
Posttransplant Diabetes Mellitus
0.6842 0.5431
0.11 0.13
Time Posttransplantation (years) 0.0795 0.02
Immunosuppressive Medications:
Calcineurin Inhibitor
Adjunctive Antiproliferative Agent Prednisolone
0.8011 0.0826 0.6651
0.19 0.88 0.19
Total Calorie Intake (kcal/day) 0.0178 0.49
Saturated Fat intake (g/day) 0.0031 0.82
Total Fructose Intake (g/day) 0.0042 0.51
Physical Activity Level (hours/week) 0.0156 0.69
Sleep Quality (PSQI score) 0.0551 0.26
Endotoxin Level (EU/mL) 0.0211 0.93
UACR (mg/mmol) 0.0116 0.36
Obesity (BMI≥30 kg/m2) 0.4472 0.28
*For continuously-distributed variables, coefficient reported per unit increase in predictor variable; for gender, coefficient shown for male versus female.
Table S8: Univariate Associations of Covariates with Raised Diastolic Blood Pressure
Logistic Regression Coefficient* p value Demographic and Social Parameters
Age (years) 0.0246 0.07
Male Gender 0.0276 0.56
Ethnicity:
Non-Caucasian (South Asian, African-Caribbean, and Others) 0.1196 0.66
Diabetes status:
Diabetic Pretransplant
Posttransplant Diabetes Mellitus
0.8941 0.6549
0.07 0.08
Time Posttransplantation (years) 0.0278 0.37
Immunosuppressive Medications:
Calcineurin Inhibitor
Adjunctive Antiproliferative Agent Prednisolone
1.8356 0.1321 0.3965
0.08 0.38 0.37
Total Calorie Intake (kcal/day) 0.8084 0.28
Saturated Fat intake (g/day) 0.0658 0.89
Total Fructose Intake (g/day) 0.0016 0.76
Physical Activity Level (hours/week) 0.0276 0.51
Sleep Quality (PSQI score) 0.0239 0.63
Endotoxin Level (EU/mL) 0.4182 0.09
UACR (mg/mmol) 0.0107 0.17
Obesity (BMI≥30 kg/m2) 0.2891 0.46
*For continuously-distributed variables, coefficient reported per unit increase in predictor variable; for gender, coefficient shown for male versus female.